Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.975 USD | -1.25% | -5.29% | -83.14% |
09/05 | EFFECTOR Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04/04 | Health Care Down on Retreat From Risk -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-83.14% | 94.09L | |
+7.11% | 11TCr | |
+10.14% | 11TCr | |
-12.31% | 2.22TCr | |
+0.44% | 2.13TCr | |
-4.18% | 1.9TCr | |
-37.85% | 1.85TCr | |
-9.29% | 1.68TCr | |
+38.65% | 1.25TCr | |
-24.90% | 808.97Cr |
- Stock Market
- Equities
- EFTR Stock
- News eFFECTOR Therapeutics, Inc.
- eFFECTOR Therapeutics : Credit Suisse Starts eFFECTOR Therapeutics at Outperform With $20 Price Target